Latest News in the pharma Industry

Biopharma News

Amgen's Talimogene Laherparep?vec Reduced Size Of Melanoma Tumours in New Phase III Retrospect?ive Analysis

Amgen's Talimogene Laherparep?vec Reduced Size Of Melanoma Tumours in New Phase III Retrospect?ive Analysis

17 Mar 2014

Read more 
Novozymes Biopharma to Collaborate with Janssen to Evaluate Proprietary VELTIS Half-Life Extension Technology

Novozymes Biopharma to Collaborate with Janssen to Evaluate Proprietary VELTIS Half-Life Extension Technology

14 Mar 2014

Read more 
Licensing Out of the First Biosimilar Developmen?t Project Already Enables Extension of the Product Pipeline as of 2014

Licensing Out of the First Biosimilar Developmen?t Project Already Enables Extension of the Product Pipeline as of 2014

12 Mar 2014

Read more 
Olympus Biotech Announces Reduced Sales Prices for New Hampshire Biopharmaceutical Manufacturing Facility

Olympus Biotech Announces Reduced Sales Prices for New Hampshire Biopharmaceutical Manufacturing Facility

11 Mar 2014

Read more 
Cevec Announces that CAP Cells Produce High Titers of RSV Vaccine

Cevec Announces that CAP Cells Produce High Titers of RSV Vaccine

10 Mar 2014

Read more 
Human Longevity Inc. Launched to Promote Healthy Ageing Using Advances in Genomics and Stem Cell Therapies

Human Longevity Inc. Launched to Promote Healthy Ageing Using Advances in Genomics and Stem Cell Therapies

6 Mar 2014

Read more 
Malvern Instrument?s Announces Guest Presenter for March 18th Protein Characterisation Webinar

Malvern Instrument?s Announces Guest Presenter for March 18th Protein Characterisation Webinar

5 Mar 2014

Read more 
Succinity Produces First Commercial Quantities of Bio-Based Succinic Acid

Succinity Produces First Commercial Quantities of Bio-Based Succinic Acid

3 Mar 2014

Read more 
New Liquid Chromatography Column Separates Challenging Glycans and Glycan Isomers

New Liquid Chromatography Column Separates Challenging Glycans and Glycan Isomers

3 Mar 2014

Read more 
Bavarian Nordic's MVA-BN Vaccine Platform Selected by U.S. Department of Defense for New Vaccine Development

Bavarian Nordic's MVA-BN Vaccine Platform Selected by U.S. Department of Defense for New Vaccine Development

27 Feb 2014

Read more 
Plasticell Signs Deal with JCR Pharmaceut?icals to use CombiCult Stem Cell Technology in Japan

Plasticell Signs Deal with JCR Pharmaceut?icals to use CombiCult Stem Cell Technology in Japan

24 Feb 2014

Read more 
Catalent Appoint News Vice President and General Manager for European Softgel Business

Catalent Appoint News Vice President and General Manager for European Softgel Business

21 Feb 2014

Read more